Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Insider Reports History

Location
Boston, MA
Signature
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. By: Wellington Management Company LLP, as Investment Adviser By: /s/ Jennifer C. Boylan, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. 10%+ Owner Class A Common Stock 897,671 $68,348,670 $76.14 02 Aug 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Common Stock 2,495,571 $24,955,710 $10.00 21 Jun 2021 Direct
Zenas BioPharma, Inc. 10%+ Owner Common Stock 801,624 $13,627,608 $17.00 16 Sep 2024 Direct
Acrivon Therapeutics, Inc. 10%+ Owner Common Stock 888,130 $3,863,366 $4.35 17 Nov 2022 Direct
Boundless Bio, Inc. 10%+ Owner Common Stock 556,233 02 Apr 2024 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 194,108 22 Jul 2024 Direct
Acrivon Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 17 Nov 2022 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 22 Jul 2024 Direct
Boundless Bio, Inc. 10%+ Owner Series B Preferred Stock 0 02 Apr 2024 Direct
Boundless Bio, Inc. 10%+ Owner Series C Preferred Stock 0 02 Apr 2024 Direct
Nuvalent, Inc. 10%+ Owner Series B Preferred Stock 0 02 Aug 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series A-2 Preferred Stock 0 21 Jun 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 21 Jun 2021 Direct
Zenas BioPharma, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 Direct
Zenas BioPharma, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 Direct
Zenas BioPharma, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 16 Sep 2024 Direct

Insider Reports Filed by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZBIO Zenas BioPharma, Inc. 16 Sep 2024 6 $0 4 10%+ Owner 18 Sep 2024, 17:16
ZBIO Zenas BioPharma, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 21:45
ARTV Artiva Biotherapeutics, Inc. 22 Jul 2024 3 +$499,994 4 10%+ Owner 22 Jul 2024, 20:28
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 10%+ Owner 18 Jul 2024, 20:06
BOLD Boundless Bio, Inc. 02 Apr 2024 4 $0 4 10%+ Owner 02 Apr 2024, 20:42
BOLD Boundless Bio, Inc. 27 Mar 2024 0 $0 3 10%+ Owner 27 Mar 2024, 21:07
ACRV Acrivon Therapeutics, Inc. 17 Nov 2022 2 $0 4 10%+ Owner 21 Nov 2022, 12:22
ACRV Acrivon Therapeutics, Inc. 09 Nov 2022 0 $0 3 10%+ Owner 09 Nov 2022, 19:51
NUVL Nuvalent, Inc. 02 Aug 2021 2 $0 4 10%+ Owner 03 Aug 2021, 20:01
NUVL Nuvalent, Inc. 28 Jul 2021 0 $0 3 10%+ Owner 28 Jul 2021, 21:29
VERV Verve Therapeutics, Inc. 21 Jun 2021 4 $0 4 10%+ Owner 22 Jun 2021, 17:14
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 19:18